Public Reporting

Review our ACO structure and historical performance

ACO Name and Location

South Texas ACO Clinical Partners LLC
Address
367 S. Gulph Road, King of Prussia, PA 19406
Primary Contact
Fred Torres - (956) 490-5759

ACO Organizational Information

ACO Participants

 

ACO Participants ACO Participant in Joint Venture (Enter Y or N)
Adonis Zuniga-Goldwater MD N
Agustin B Mego Md Pa N
Andres Garcia Zuniga, M.D.,PA N
Arturo Garza Gongora N
Benjamin Fano MD PA Y
Carlos Hornedo N
CARLOS N HORNEDO III DO PA N
Clinica Sagrado Corazon N
David H Cruz MD PA N
Dr Americo M Baca PLLC N
Eloy Zamarron, Jr MD, PA Y
FALFURRIAS MEDICAL GROUP LLP N
Family Medicine Associates PA N
Garza Medical Associates Y
Humberto Nunez, MD PA Y
Humberto Varela, MD N
JOSE A ESCANDON, MD PA N
Jose Garcia Y
Jose Roel Maldonado Jr MD PA N
Juana Maria Espejo Md Pa N
Kallumadanda PLLC N
LAREDO MINOR EMERGENCY CLINIC PA Y
Laredo Physicians Group N
Laredo Premier Healthcare, PLLC Y
Luis Benavides Y
MARY PLATTNER N
McAllen Hospitalist Group, PLLC Y
Miguel Villarino MD PA N
MONZER H YAZJI MD & ASSOCIATES PA Y
Pablo Olmedo N
RAFAEL J DELIZ MD PA N
Ruben D Bocanegra MD PA Y
South Laredo Family Clinic PA Y
Winder Vasquez N
ACO Governing Body

 

Last name First name Title/Position Member’s voting power (expressed as a percentage or number) Membership type ACO participant legal business name/DBA, if applicable
Yazji Monzer Chair 1 ACO Participant Representative Monzer H Yazji MD & Associates PA
Benavides Luis Physician 1 ACO Participant Representative Laredo Premier Healthcare, PLLC
Garcia Jose Physician 1 ACO Participant Representative Jose Garcia
Garza-Gongora Arturo Physician 1 ACO Participant Representative Arturo Garza Gongora
Alvarado Conrado Other 1 ACO Beneficiary Representative N/A
Key ACO clinical and administrative leadership

ACO Executive: Kamal Jemmoua
Medical Director: Monzer Yazji
Compliance Officer: Philip Ramirez
Quality Assurance/Improvement Officer: Jose Garcia

Associated committees and committee leadership
Committee Name Committee Leader Name and Position
Clinical Committee Dr. Andrew Levine, Chair
Finance Committee Dr. Luis Benavides, Chair
Quality Assurance and Improvement Committee Dr. Jose Garcia, Chair

 

Shared Savings and Losses

Amount of Shared Savings/Losses

  • First Agreement Period
    • Performance Year 2019, $8,632,047
    • Performance Year 2018, $6,752,936
    • Performance Year 2017, $0

Shared Savings Distribution

  • First Agreement Period
    • Performance Year 2019
      • Proportion invested in infrastructure: 10%
      • Proportion invested in redesigned care processes/resources: 20%
      • Proportion of distribution to ACO participants: 70%
    • Performance Year 2018
      • Proportion invested in infrastructure: 10%
      • Proportion invested in redesigned care processes/resources: 20%
      • Proportion of distribution to ACO participants: 70%
    • Performance Year 2017
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
Quality Performance Results

2019 Quality Performance Results:

ACO $ Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 88.18 85.86
ACO-2 CAHPS: How Well Your Providers Communicate 93.87 94.11
ACO-3 CAHPS: Patients’ Rating of Provider 92.91 92.69
ACO-4 CAHPS: Access to Specialists 86.11 81.54
ACO-5 CAHPS: Health Promotion and Education 62.57 60.44
ACO-6 CAHPS: Shared Decision Making 63.60 62.78
ACO-7 CAHPS: Health Status/Functional Status 69.75 73.79
ACO-34 CAHPS: Stewardship of Patient Resources 28.48 26.17
ACO-45 CAHPS: Courteous and Helpful Office Staff 89.77 92.84
ACO-46 CAHPS: Care Coordination 84.07 86.89
ACO-8 Risk Standardized, All Condition Readmission 14.77 14.86
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 54.36 58.15
ACO-43 Ambulatory Sensitive Condition Acute Composite (AHRQ Prevention Quality Indicator (PQI) #91) 1.75 1.87
ACO-13 Falls: Screening for Future Fall Risk 96.84 84.04
ACO-14 Preventive Care and Screening: Influenza Immunization 80.30 74.77
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 95.65 78.04
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 77.69 70.40
ACO-19 Colorectal Cancer Screening 80.69 70.76
ACO-20 Breast Cancer Screening 82.66 73.84
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 77.08 82.17
ACO-27 Diabetes: Hemoglobin A1c Poor Control (>9%) 14.12 13.88
ACO-28 Controlling High Blood Pressure 70.00 75.04

Note: In the Quality Performance Results file(s) above, search for “South Texas ACO Clinical Partners LLC” to view the quality performance results. This ACO can also be found by using the ACO ID A3367 in the public use files on data.cms.gov.

Payment Rule Waivers

Skilled Nursing Facility (SNF) 3-day Rule Waiver:

Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR §425.612.

Types of ACO participants, or combinations of participants, that formed the ACO

ACO professionals in a group practice arrangement
Networks of individual practices of ACO professionals
Hospital employing ACO professionals